Trial intelligence / Profile preview

Benjakul Extract vs Loratadine in Allergic Rhinitis

NCT03376594Phase 2Completed

Sponsor
Thammasat University
Start
Jul 2017
Primary completion
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of benjakul in allergic rhinitis (AR), sponsored by Thammasat University. Started Jul 2017; status: completed.

02

Drugs

benjakul
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT03376594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03376594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call